Citations 4

Multiple Sclerosis Misdiagnosis in Cerebral Autosomal Dominant Arteriopathy With Subcortical Infarcts and Leukoencephalopathy

Neurology Genetics | August 26, 2026 | Volume: 12 | Issue: 5 | Pages: No page available

10.1212/nxg.0000000000200430 | PMID 42689243

Multiple Sclerosis Misdiagnosis in CADASIL: A Genotype-Mis-Phenotype Study (P8-20.009)

Neurology | June 10, 2026 | Volume: 106 | Issue: 11_Supplement_1 | Pages: No page available

10.1212/wnl.0000000000215130

Toward allele-specific targeting therapy and pharmacodynamic marker for spinocerebellar ataxia type 3

Science Translational Medicine | October 21, 2020 | Volume: 12 | Issue: 566 | Pages: No page available

10.1126/scitranslmed.abb7086 | PMID 33087504

PolyQ ATXN3 is a pharmacodynamic marker for SCA3, and a SNP associated with the expanded allele may serve to specifically target mutant ATXN3 .
MOG antibodies in combined central and peripheral demyelination syndromes

Neurology Neuroimmunology & Neuroinflammation | September 11, 2018 | Volume: 5 | Issue: 6 | Pages: No page available

10.1212/nxi.0000000000000503 | PMID 30246057